Literature DB >> 8500727

Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium.

M M Berenson1, T D Johnson, N R Markowitz, K N Buchi, W S Samowitz.   

Abstract

BACKGROUND: Antireflux therapy has generally failed to induce regression of Barrett's epithelium. It was hypothesized that squamous epithelium could be restored if the columnar tissue was ablated while gastric acid secretion was suppressed.
METHODS: Ten white men with Barrett's esophagus received 40 mg of omeprazole daily. Thereafter, every 2-5 weeks they underwent videotaped endoscopies to argon laser photoablate columnar tissue, obtain biopsy specimens, and assess results. Squamous re-epithelialization was assessed by correlation of videotapes and directed biopsies.
RESULTS: Patients had one to eight areas ablated, totaling 0.5-12.0 cm2. Videotape assessments were corroborated by biopsy in all but one instance. Thirty-eight of 40 treatment locations partially or completely re-epithelialized with squamous tissue. Squamous regrowth appeared to occur by spread from contiguous squamous borders and de novo from glandular tissue. Regrowth was influenced by the extent of squamous borders and completeness of ablations. Nonablated glandular tissue persisted beneath squamous epithelium.
CONCLUSIONS: Ablation of Barrett's epithelium and suppression of acid secretion facilitated squamous re-epithelialization. A progenitor cell within the metaplastic tissue has the potential to differentiate normally.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500727     DOI: 10.1016/0016-5085(93)90646-t

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed?

Authors:  R Ackroyd; N J Brown; T J Stephenson; C J Stoddard; M W Reed
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

2.  Barrett's oesophagus and proton pump inhibitors: a pathological perspective.

Authors:  N A Shepherd
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

3.  Photoablation of Barret's esophagus.

Authors:  K K Wang
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

Review 4.  Reversal of Barrett's esophagus with electrocoagulation and laser.

Authors:  R E Sampliner
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

5.  Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus.

Authors:  H Tigges; K H Fuchs; J Maroske; M Fein; S M Freys; J Müller; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

Review 6.  Endoscopic ablation of Barrett's esophagus.

Authors:  M B Fennerty
Journal:  Curr Gastroenterol Rep       Date:  1999-06

7.  Argon plasma coagulation therapy for ablation of Barrett's oesophagus.

Authors:  J Deviere
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

8.  Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

Authors:  R C Fitzgerald
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 9.  High grade dysplasia: surveillance, mucosal ablation, or resection?

Authors:  Robert J Korst; Nasser K Altorki
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 10.  Optical biopsy: a new frontier in endoscopic detection and diagnosis.

Authors:  Thomas D Wang; Jacques Van Dam
Journal:  Clin Gastroenterol Hepatol       Date:  2004-09       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.